SBF 120 Values: Comprehensive Guide to Investing in 2025

The SBF 120 values represent an unavoidable opportunity for investors looking to expose themselves to the largest listed French companies. This exhaustive guide reviews the composition, recent trends, essential analysis criteria, and the best strategies to optimize your investments in the leading companies of the SBF 120 index in 2025.

Introduction to SBF 120 Values

The SBF 120 index is a major reference on the French stock market. It groups together the 120 most important French companies by their market capitalization and liquidity, thus offering a diversified overview of the national economy. Investors find in this index a powerful tool to naturally diversify their portfolio and benefit from the dynamism of the largest French stocks.

What is the SBF 120?

The SBF 120 (French Stock Exchanges 120) includes each year the 40 values of the CAC 40 along with 80 other major French companies listed on Euronext Paris. The index covers all sectors of the economy, such as industry, healthcare, finance, consumption, technology, energy, or real estate. It is managed and revised by Euronext during regular meetings to ensure optimal representation of the French economic fabric.

Why is the SBF 120 so important for investors?

Exposure to the SBF 120 allows:

  • Natural sectoral diversification, limiting the risk associated with a particular sector;
  • High liquidity, facilitating the purchase and sale of shares;
  • Access to the strongest French capitalizations, known for their relative stability and long-term earning potential;
  • Representation of the French economic fabric, from heavy industry to healthtech, through luxury, banking, or green technologies.

Analysis of SBF 120 Values in 2025

To successfully invest in SBF 120 values, it is essential to understand the major trends that shape the market in 2025, know the current composition of the index, and be able to analyze each type of value to adapt your strategy.

General Trends of the SBF 120 Market in 2025

In 2025, the French stock market remains solid despite some headwinds on the macroeconomic level. Companies in the SBF 120 show great resilience, driven by:

  • Robust balance sheets, largely debt-free after the health crisis;
  • Sustained innovation policies, particularly in the technology, industrial, luxury, and biotechnology sectors;
  • A renewed interest of foreign investors in the Paris stock exchange;
  • A persistent external growth dynamic, with frequent merger and acquisition operations.

Sectoral Composition of the SBF 120

The SBF 120 stands out for its high level of diversification. One finds:

  • Financial sector : BNP Paribas, Société Générale, AXA…
  • Industry/Energy : Vinci, Bouygues, TotalEnergies, Engie, Schneider Electric
  • Health/Biotechnology : Sanofi, Sartorius Stedim Biotech, Abivax, Eurofins Scientific…
  • Luxury/Consumer Goods : LVMH, Kering, Hermès, L’Oréal, Danone…
  • Technology : Capgemini, Dassault Systèmes, Teleperformance, STMicroelectronics…
  • Real Estate : Unibail-Rodamco-Westfield, Klepierre, Gecina…

Concrete Example : Abivax, Biotechnology of the CAC 40

To illustrate the analysis of a value in the CAC 40 within the health sector, let's consider Abivax, a biotechnology company listed on the Paris stock exchange and integrated into the index.

  • Industry : Health
  • Sub-industry : Biotechnology / Pharma
  • Current Price (November 2025) : between €84 and €90 depending on the session
  • Market Capitalization : over one billion euros, indicating its status as a major listed company
  • Dividend Yield : 0 % (Abivax does not pay dividends, like most biotechs in the index)

This typical profile demonstrates the contrast with micro-cap stocks or penny stocks, confirming that the CAC 40 comprises only major companies in the French market.

Other Biotechs in the CAC 40 in 2025

Biotech is not widely represented in the index, but companies such as Sartorius Stedim Biotech or Eurofins Scientific display market capitalizations well above one billion euros and high per-share prices. The classic data from the Paris Stock Exchange confirm that all these values are far beyond a market capitalization of €879,719 and a share price of a few cents.

Case to Avoid Reproducing : Confusion with Foreign Micro-Caps

It sometimes happens that investors confuse companies such as Vali Rx plc, a biotechnology company listed on the London Stock Exchange, with values in the CAC 40. However, this company is not part of the panel of major French companies and is therefore never referenced in the CAC 40. Ultra-low prices (a few cents) and low market capitalizations correspond exclusively to foreign micro-caps, totally absent from the Parisian index.

Fundamental Criteria for Selecting a Value in the CAC 40

The analysis of companies in the CAC 40 relies on a battery of objective criteria that allow evaluating their attractiveness for the modern investor:

  • Market Capitalization : often exceeds one billion euros ;
  • Liquidity : significant trading volumes each day, ensuring good capital circulation ;
  • Industry Dynamics : growth, innovation, digital transformations...;
  • Profitability : margins, net profits, and ability to generate cash flow ;
  • Dividend : some values (luxury, finance, industry) offer a significant yield, while other sectors, such as biotechnology, generally do not pay dividends ;
  • Stock Price Evolution : historical data, volatility, medium-to-long-term trend ;
  • ESG Rating : Environmental, Social, and Governance criteria, increasingly scrutinized by responsible investors.

Focusing on Beta

The beta of a stock in the SBF 120 measures its volatility relative to the overall market. Most large companies in the index display a beta ranging between 0.7 and 1.5. A strongly negative beta is extremely rare and never applies to major French biotech companies. This parameter, sometimes difficult to find in public databases, deserves verification on professional platforms for a precise approach to risk management.

Investment Strategies in the SBF 120 in 2025

Value Investing

This strategy involves targeting undervalued companies relative to their potential, by monitoring ratios such as:

  • PER (Price Earnings Ratio) ;
  • Tangible Book Value ;
  • Balance Sheet Strength (low debt, strong cash reserves) ;
  • Regular Dividend and dividend growth.

Growth Investing

The SBF 120 includes excellent growth stocks, particularly in health, technology, and luxury. Selection criteria include:

  • Double-digit revenue or net income growth rates ;
  • Innovation Dynamics : R&D investments, patents filed, new products ;
  • International Presence and development in emerging markets ;
  • Product Launch Pipeline for biotechs and pharma ;
  • Improving Operating Margins.

Diversification and Risk Management

The SBF 120 is ideal for diversification, provided that positions are well distributed among cyclical, defensive, and growth sectors. Some concrete suggestions:

  • Sectoral Diversification : it is recommended not to focus solely on one sector, even if it performs well (e.g., luxury, banks, energy) ;
  • Geographic Diversification : some SBF 120 companies operate internationally. This cushions French or European shocks ;
  • Diversification by Size : mix CAC 40 leaders and mid-cap SBF 120 values ;
  • Dynamic Management : adjust your portfolio regularly according to the economic situation and corporate results.

How to Invest Wisely in SBF 120 Stocks?

To optimize exposure to the index, the investor can:

  • Choose to buy stocks directly through a brokerage account or a PEA (Plan d'Épargne en Actions);
  • Use ETFs or mutual funds replicating the SBF 120 for instant diversification;
  • Combine active management (stock picking) and passive management (ETFs) according to their risk profile;
  • Adopt a long-term approach by taking advantage of the cumulative effect of reinvesting dividends on distributing stocks;
  • Ensure to monitor the news of the index's values: quarterly results, upward revisions, announcements of mergers or acquisitions.

Evolving Factors and Performance in 2025

The evolution of SBF 120 values in 2025 depends on several elements:

  • European monetary policy (interest rates, controlled or uncontrolled inflation)
  • International economic conditions (global growth, trade/commodity tensions)
  • Technological innovation: increasing influence of AI, connected health, energy transition
  • ESG regulation: gradual rise of socially responsible investment and environmental criteria.

Focus on Some Key Values of the SBF 120

LVMH, Global Leader in Luxury

LVMH remains one of the largest European market caps, with an active external growth strategy, an unmatched portfolio of brands, and stable earnings dynamics even during periods of economic tension. The group regularly distributes a strong dividend and records record operating margins in the luxury industry.

Sartorius Stedim Biotech, Champion of Biotechnology

Sartorius Stedim Biotech stands out for its continuous growth in providing equipment and technologies for bioproduction. Its positioning allows it to benefit from the global momentum of biomedical research and the rise of innovative therapies.

Sanofi, Pillar of French Healthcare

Sanofi, a major player in global pharmaceutical research, benefits from diversified revenues between mature drugs and therapeutic innovations. Its regular dividend distribution policy makes it a defensive value of the SBF 120.

Air Liquide and Schneider Electric, Pillars of Industry and Energy Transition

Air Liquide and Schneider Electric are emblematic of French industrial expertise and their ability to adapt to ecological and digital transition challenges. These companies have robust stock market histories, steady growth, and advanced sustainable development policies.

Understanding Risks and Managing Volatility Phases

No investment strategy is effective without managed risk control. SBF 120 values may suffer temporary corrections during economic crises or sectoral transformations (e.g., banking sector laws, technological disruptions in healthcare, etc.). Therefore, it is advisable to:

  • Regularly follow economic news and revisions of guidance from companies;
  • Actively diversify your portfolio to limit the impact of bad news on a single holding;
  • Use stop-loss and price targets to protect gains and limit potential losses.

Perspectives and potential of the SBF 120 through 2025-2030

Thanks to the dynamic transformation of many traditional sectors (green industry, digitization, new health, AI...), the SBF 120 offers significant growth potential in the medium to long term. The rise of industrial ETIs, the increase in intellectual property, international openness, and the growing importance of ESG issues should continue to drive the index towards new peaks in valuation and economic influence within Europe.

Conclusion: Why choose the SBF 120 for your equity investments in 2025?

The SBF 120 remains the preferred barometer of France's economic health and an ideal playing field for investors seeking diversification, liquidity, and financial stability. Whether it is capturing the dynamism of luxury, technology, pharmaceuticals, or energy transition, all strategies can find their place in the composition of a portfolio structured around this index. In 2025, it still constitutes a relevant basis for all approaches, from value investing to growth, including dividends and sectoral stock picking.

To remember: investing in the right value of the SBF 120 requires combining fundamental analysis, trend following, rigor in risk management, and anticipation of future transformations of the real economy. It is by maintaining this global vision that the investor will be able to navigate market cycles and fully capture the potential of the SBF 120 in service of his/her wealth management strategy.